HOME >> MEDICINE >> NEWS
Rockefeller University researchers are changing the face of drug addiction treatment

dea of operant conditioning, which proposes that behavior is more likely to continue if it is reinforced. In the mid-70's, Maxine Stitzer, Ph.D., from Johns Hopkins University and a co-author of this paper, began to test the effectiveness of this theory and intervention method on patients addicted to drugs.

"There was a debate between the scientific and the traditional worlds of drug treatment," says Kellogg. "At first, the traditionalists were not able to take in a behavioral perspective as they saw addiction as an innate disease; therefore external circumstances should not affect an addicted person's behavior. But those ideas are changing now, and that change is part of our story."

The National Institute of Drug Addiction (NIDA) developed the Clinical Trials Network to both test and publicize various science-based addiction treatments, and the contingency management program was one of the first chosen to study. At a conference sponsored by NIDA, Kellogg, who is the scientific director for the contingency management intervention in New York, met Peter Coleman and Marylee Burns, from the Office of Behavioral Health at the HHC, who are contributing authors to the paper. Their meeting produced one of the largest adoptions ever done of contingency management, which involved five addiction clinics in New York City.

"The Health and Hospitals Corporation was already preparing to apply something similar to the contingency management approach," Kellogg says. "They were thinking of giving people rewards when they reached significant treatment benchmarks, such as holding a job for six months. Using the science of operant conditioning, we suggested to them that you could achieve a better outcome if you don't simply reward the attainment of goals, but, instead, you reinforce all of the steps along the way."

"Scott developed the concept of a modified, practical but formal contingency management intervention within a community-based treatment sett
'"/>

Contact: Kristine Kelly
kkelly@rockefeller.edu
212-327-7146
Rockefeller University
1-Apr-2005


Page: 1 2 3

Related medicine news :

1. Rockefeller Foundation will not abandon its commitments to public health
2. Indiana University Imaging Center receives $6M grant for kidney research
3. University hospitals wins multiple national IT awards for electronic patient data bank
4. RAND presents first Victor Fuchs Research Award to economists at Carnegie Mellon University
5. University research wins royal accolade
6. New Orleans levee report finished by panel including University of Texas at Austin engineer
7. Boston University School of Medicine faculty member receives honorary degree from alma mater
8. NY-Presbyterian Hospital/Columbia University Medical Center doctors present at 2007 AUA Meeting
9. Emory University researchers find persistent and severe asthma associated with obesity
10. Mid Sweden University leads development of digital color x-rays
11. $2.6M grant awarded to New York University College of Nursing

Post Your Comments:
(Date:8/3/2015)... ... August 03, 2015 , ... A July 13 article from The Daily ... to Release Natural Painkiller That Can Last 'For Five Weeks'" discusses the use ... the new study showed that harvesting stem cell-rich bone marrow from the hip, known ...
(Date:8/3/2015)... ... ... Illinois Health & Science (IHS) has completed the purchase of IBA Molecular North ... NA’s cyclotron sites and research and development facilities. , “We are excited ... a large manufacturing hub in Noblesville, Indiana,” said Ken Smithmier, President and CEO of ...
(Date:8/3/2015)... ... August 03, 2015 , ... Hub International Insurance ... Williams has joined its growing California employee benefits division. Mr. Williams will ... his clients. Mr. Williams will be joining the newly integrated Northern California employee ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... ... Government Programs, with accountability for overall performance of the company’s Medicare and Federal ... focus of Cambia’s strategy to deliver better health for members. In this role, ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... provider of medical information, risk management and investigative services, has introduced a ... toward focused, expert information solutions that improve business outcomes for its customers. ...
Breaking Medicine News(10 mins):Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3Health News:Illinois Health & Science Expands Nuclear Medicine Footprint With Purchase of IBA Molecular North America, Inc. 2Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2Health News:Cambia Health Solutions Names Scott Powers President of Government Programs 2Health News:EMSI Announces New Branding: Powerful Information. Improved Outcomes. 2
(Date:8/3/2015)... -- Encision Inc. (PK:ECIA), a medical device company owning patented ... minimally invasive surgery, today announced financial results for its ... The Company posted quarterly net revenue of ... thousand, or $(0.02) per share. These results compare to ... of $202 thousand, or $(0.02) per share, in the ...
(Date:8/2/2015)... , Aug. 3, 2015  Isis Pharmaceuticals, Inc. ... a strategic collaboration to discover and develop antisense ... new collaboration builds on a broad existing relationship ... approach in these therapeutic areas using novel RNA-targeted ... use of its antisense technology to diseases of ...
(Date:7/31/2015)... N.C. , July 31, 2015  In today,s ... customers who are increasingly mobile, increasingly connected, and increasingly ... growing variety of customer interaction channels and tools is ... including social media. According to research ... over the counter (OTC) segment in a call center ...
Breaking Medicine Technology:Encision Reports First Quarter Fiscal Year 2016 Results 2Encision Reports First Quarter Fiscal Year 2016 Results 3Encision Reports First Quarter Fiscal Year 2016 Results 4Encision Reports First Quarter Fiscal Year 2016 Results 5AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 2AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 3AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 4Best Practices in Building World-Class Consumer & Over-the-Counter Call Centers 2
Cached News: